Advertisement
ASIX vs CBT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASIX is a Hold and CBT is a Hold.
ASIX in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 24, 2026
ASIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 37 of 50 cases where ASIX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on ASIX as a result. In 53 of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for ASIX just turned positive on October 01, 2026. Looking at past instances where ASIX's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
Following a +2.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASIX advanced for three days, in 197 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 56 cases where ASIX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for ASIX entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.535) is normal, around the industry mean (10.717). ASIX has a moderately high P/E Ratio (55.639) as compared to the industry average of (27.649). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (3.769). Dividend Yield (0.041) settles around the average of (0.044) among similar stocks. P/S Ratio (0.290) is also within normal values, averaging (0.578).
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. ASIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
CBT's RSI Indicator ascends from oversold territory
The RSI Indicator for CBT moved out of oversold territory on October 13, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 17 of the 22 cases the stock moved higher. This puts the odds of a move higher at 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for CBT just turned positive on October 15, 2026. Looking at past instances where CBT's MACD turned positive, the stock continued to rise in 33 of 50 cases over the following month. The odds of a continued upward trend are 66%.
Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBT advanced for three days, in 209 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBT as a result. In 66 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for CBT entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.523) is normal, around the industry mean (6.363). P/E Ratio (21.975) is within average values for comparable stocks, (209.940). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (1.548). Dividend Yield (0.023) settles around the average of (0.013) among similar stocks. P/S Ratio (1.138) is also within normal values, averaging (48.960).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. CBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
ASIX | CBT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 27 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 12 Undervalued | 26 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 65 | |
SMR RATING 1..100 | 91 | 65 | |
PRICE GROWTH RATING 1..100 | 72 | 58 | |
P/E GROWTH RATING 1..100 | 2 | 6 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ASIX's Valuation (12) in the Chemicals Specialty industry is in the same range as CBT (26) in the Industrial Specialties industry. This means that ASIX’s stock grew similarly to CBT’s over the last 12 months.
CBT's Profit vs Risk Rating (65) in the Industrial Specialties industry is somewhat better than the same rating for ASIX (100) in the Chemicals Specialty industry. This means that CBT’s stock grew somewhat faster than ASIX’s over the last 12 months.
CBT's SMR Rating (65) in the Industrial Specialties industry is in the same range as ASIX (91) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to ASIX’s over the last 12 months.
CBT's Price Growth Rating (58) in the Industrial Specialties industry is in the same range as ASIX (72) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to ASIX’s over the last 12 months.
ASIX's P/E Growth Rating (2) in the Chemicals Specialty industry is in the same range as CBT (6) in the Industrial Specialties industry. This means that ASIX’s stock grew similarly to CBT’s over the last 12 months.
| ASIX | CBT | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 77% |
| Stochastic ODDS (%) | 1 day ago 79% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 69% |
| MACD ODDS (%) | 1 day ago 69% | 1 day ago 66% |
| TrendWeek ODDS (%) | 1 day ago 70% | 1 day ago 67% |
| TrendMonth ODDS (%) | 1 day ago 70% | 1 day ago 68% |
| Advances ODDS (%) | 12 days ago 65% | 13 days ago 67% |
| Declines ODDS (%) | 6 days ago 74% | 6 days ago 67% |
| BollingerBands ODDS (%) | 1 day ago 74% | N/A |
| Aroon ODDS (%) | 1 day ago 69% | 1 day ago 68% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASIX’s FA Score shows that 2 FA rating(s) are green while CBT’s FA Score has 2 green FA rating(s).
- ASIX’s FA Score: 2 green, 3 red.
- CBT’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASIX’s TA Score shows that 4 TA indicator(s) are bullish while CBT’s TA Score has 4 bullish TA indicator(s).
- ASIX’s TA Score: 4 bullish, 3 bearish.
- CBT’s TA Score: 4 bullish, 3 bearish.
Price Growth
ASIX (@Chemicals: Major Diversified) experienced а +0.80% price change this week, while CBT (@Chemicals: Specialty) price change was -0.83% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Major Diversified industry was +2.48%. For the same industry, the average monthly price growth was -5.62%, and the average quarterly price growth was -21.87%.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -2.62%. For the same industry, the average monthly price growth was -3.89%, and the average quarterly price growth was -5.01%.
Reported Earning Dates
ASIX is expected to report earnings on Nov 04, 2026.
CBT is expected to report earnings on Nov 02, 2026.
Industries' Descriptions
@Chemicals: Major Diversified (+2.48% weekly)The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.
@Chemicals: Specialty (-2.62% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DIVI | 42.54 | 0.07 | +0.16% |
| Franklin International Core Dividend Tilt Index Fund (DIVI) | |||
| CVGD | 26.27 | N/A | N/A |
| CresAlta Global Dividend ETF (CVGD) | |||
| MAYW | 35.54 | -0.19 | -0.53% |
| AllianzIM U.S. Equity Buffer20 May ETF (MAYW) | |||
| ERY | 7.68 | -0.40 | -4.95% |
| Direxion Daily Energy Bear 2X ETF (ERY) | |||
| EOSU | 1.38 | -0.67 | -32.68% |
| T-REX 2X Long EOSE Daily Target ETF (EOSU) | |||
ASIX and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASIX has been closely correlated with AVNT. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ASIX jumps, then AVNT could also see price increases.
| Ticker / NAME | Correlation To ASIX | 1D Price Change % | ||
|---|---|---|---|---|
| ASIX | 100% | -0.79% | ||
| AVNT - ASIX | 72% Closely correlated | -0.05% | ||
| SCL - ASIX | 70% Closely correlated | +0.26% | ||
| IOSP - ASIX | 66% Closely correlated | +0.22% | ||
| LYB - ASIX | 64% Loosely correlated | +2.14% | ||
| FUL - ASIX | 63% Loosely correlated | -0.48% | ||
More | ||||
CBT and
Correlation & Price change
A.I.dvisor indicates that over the last year, CBT has been loosely correlated with ASIX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CBT jumps, then ASIX could also see price increases.
| Ticker / NAME | Correlation To CBT | 1D Price Change % | ||
|---|---|---|---|---|
| CBT | 100% | -1.58% | ||
| ASIX - CBT | 62% Loosely correlated | -0.79% | ||
| OLN - CBT | 61% Loosely correlated | +0.64% | ||
| HUN - CBT | 55% Loosely correlated | +0.23% | ||
| DOW - CBT | 55% Loosely correlated | +0.91% | ||
| AVNT - CBT | 55% Loosely correlated | -0.05% | ||
More | ||||